SCHEMBL4908131

SCHEMBL4908131

CCOC(=O)c1c(O)c(-c2cccs2)nn(CC2(C(F)(F)F)CC2)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.40
KDM4E B2RXH2 10/20 0.40
HPGD P15428 5/20 0.40
GAA P10253 3/20 0.40
TSHR P16473 2/20 0.40
USP2 O75604 1/20 0.40
NPSR1 Q6W5P4 6/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
KEAP1 Q14145 1/20 0.39
TP53 P04637 2/20 0.39
POLB P06746 1/20 0.39
HIF1A Q16665 2/20 0.38
ADORA1 P30542 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
KMT2A Q03164 2/20 0.37
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14034290 0.80 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL4575054 0.80 KDM4E (0.45) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL14006532 0.79 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL4574585 0.79 KDM4E (0.43) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL14006667 0.79 TSHR (0.43) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL335086 0.78 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL4574364 0.76 KDM4E (0.40) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL4061711 0.70 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL3848844 0.69 KMT2A (0.54) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL5085613 0.66 FEN1 (0.44) ALDH1A1KDM4EHPGDTSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275032-A1 Pyridazinone compounds ANADYS PHARMACEUTICALS, INC. 2008-11-06 US disclosed
US-20080275032-A1 Pyridazinone compounds ANADYS PHARMACEUTICALS, INC. 2008-11-06 US disclosed
US-20080275032-A1 Pyridazinone compounds ANADYS PHARMACEUTICALS, INC. 2008-11-06 US disclosed
WO-2008082725-A1 PYRIDAZINONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2008-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275032-A1 Pyridazinone compounds HAVCR2, PLPBP, CYP3A43 ALDH1A1 1191/4885KDM4E 3033/4885HPGD 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.